We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.6B
AUM Growth
-$2.31B
Cap. Flow
-$309M
Cap. Flow %
-0.82%
Top 10 Hldgs %
14.09%
Holding
3,035
New
443
Increased
1,011
Reduced
1,232
Closed
320

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$465M
2
AMZN icon
Amazon
AMZN
+$304M
3
AAPL icon
Apple
AAPL
+$297M
4
OXY icon
Occidental Petroleum
OXY
+$286M
5
ZM icon
Zoom
ZM
+$259M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$395M
2
ATVI
Activision Blizzard
ATVI
+$373M
3
CAT icon
Caterpillar
CAT
+$297M
4
INTC icon
Intel
INTC
+$277M
5
NVDA icon
NVIDIA
NVDA
+$236M

Sector Composition

Rank Sector Weight
1 Technology 24.58%
2 Healthcare 20.45%
3 Consumer Discretionary 10.84%
4 Financials 9.26%
5 Industrials 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAVB
2701
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$9K ﹤0.01%
12,000
-49,400
-80% -$45.3K
RMTI icon
2702
Rockwell Medical
RMTI
$28.6M
$8K ﹤0.01%
153
-20
-12% -$847
DYNT
2703
DELISTED
Dynatronics Corp
DYNT
$8K ﹤0.01%
2,220
-4,920
-69% -$20.2K
CLRB icon
2704
Cellectar Biosciences
CLRB
$20.8M
$7K ﹤0.01%
36
-355
-91% -$62.1K
COCP icon
2705
Cocrystal Pharma
COCP
$11.9M
$7K ﹤0.01%
1,083
-3,392
-76% -$22.6K
CRBP icon
2706
Corbus Pharmaceuticals
CRBP
$161M
$7K ﹤0.01%
467
+90
+24% +$1.19K
AUMN
2707
DELISTED
Golden Minerals Company
AUMN
$7K ﹤0.01%
592
+12
+2% +$136
NVCN
2708
DELISTED
Neovasc Inc.
NVCN
$7K ﹤0.01%
684
-8
-1% -$89
FENG
2709
Phoenix New Media
FENG
$18.3M
$6K ﹤0.01%
1,783
-84
-4% -$364
GNLN icon
2710
Greenlane Holdings
GNLN
$1.26M
0
HSTO
2711
DELISTED
Histogen Inc. Common Stock
HSTO
$4K ﹤0.01%
730
-720
-50% -$3.65K
SDEV
2712
Stablecoin Development Corp
SDEV
$31.7M
$3K ﹤0.01%
2
-1
-33% -$1.92K
RDGT
2713
Ridgetech Inc
RDGT
$2.72M
0
PTE
2714
DELISTED
PolarityTE, Inc. Common Stock
PTE
$3K ﹤0.01%
548
-76
-12% -$879
ACRS icon
2715
Aclaris Therapeutics
ACRS
$716M
-13,300
Closed -$193K
AEMD icon
2716
Aethlon Medical
AEMD
$1.68M
-53
Closed -$79K
AEYE icon
2717
AudioEye
AEYE
$72.2M
-14,500
Closed -$102K
AFRM icon
2718
Affirm
AFRM
$24B
-33,100
Closed -$3.33M
AGIO icon
2719
Agios Pharmaceuticals
AGIO
$1.89B
-6,400
Closed -$210K
AHT
2720
Ashford Hospitality Trust
AHT
$21M
-13,704
Closed -$1.32M
ALC icon
2721
Alcon
ALC
$33.5B
-35,990
Closed -$3.13M
AMAT icon
2722
Applied Materials
AMAT
$402B
-88,500
Closed -$13.9M
AMWD
2723
DELISTED
American Woodmark
AMWD
-6,500
Closed -$424K
APLS
2724
DELISTED
Apellis Pharmaceuticals
APLS
-30,600
Closed -$1.45M
ARES icon
2725
Ares Management
ARES
$27.9B
-2,600
Closed -$211K

Similar funds

Two Sigma Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Two Sigma Advisers held 3,035 positions worth $37.6B, down 5.8% from $39.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Two Sigma Advisers's Q1 2022 filing shows 443 new, 1,011 increased, 1,232 reduced and 320 closed positions. Its largest new stake was PepsiCo: 1,100,300 shares worth $184M. The largest sale was Coca-Cola, an estimated $395M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Two Sigma Advisers's largest Q1 2022 buy was PepsiCo: 1,100,300 shares worth $184M.
  • Two Sigma Advisers added most to Adobe in Q1 2022, an estimated $465M increase.
  • Two Sigma Advisers's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $395M.
  • Two Sigma Advisers fully exited Activision Blizzard in Q1 2022, selling an estimated $373M.
  • Two Sigma Advisers's ten largest holdings make up 14% of its $37.6B portfolio in Q1 2022.
  • Two Sigma Advisers opened 443 new positions and closed 320 in Q1 2022.
  • Two Sigma Advisers's portfolio value fell 5.8% quarter-over-quarter to $37.6B.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.